- Home
- NEGG vs NSPR Comparison
NEGG vs NSPR Comparison
Compare NEGG & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- NSPR
- Stock Information
- Founded
- NEGG 2001
- NSPR 2005
- Country
- NEGG United States
- NSPR United States
- Employees
- NEGG N/A
- NSPR N/A
- Industry
- NEGG Other Specialty Stores
- NSPR Medical/Dental Instruments
- Sector
- NEGG Consumer Discretionary
- NSPR Health Care
- Exchange
- NEGG Nasdaq
- NSPR Nasdaq
- Market Cap
- NEGG 122.3M
- NSPR 99.7M
- IPO Year
- NEGG 2010
- NSPR N/A
- Fundamental
- Price
- NEGG $77.77
- NSPR $2.13
- Analyst Decision
- NEGG
- NSPR Strong Buy
- Analyst Count
- NEGG 0
- NSPR 2
- Target Price
- NEGG N/A
- NSPR $4.50
- AVG Volume (30 Days)
- NEGG 1.2M
- NSPR 70.2K
- Earning Date
- NEGG 12-01-2025
- NSPR 11-04-2025
- Dividend Yield
- NEGG N/A
- NSPR N/A
- EPS Growth
- NEGG N/A
- NSPR N/A
- EPS
- NEGG N/A
- NSPR N/A
- Revenue
- NEGG $1,313,127,000.00
- NSPR $7,779,000.00
- Revenue This Year
- NEGG N/A
- NSPR $7.48
- Revenue Next Year
- NEGG N/A
- NSPR $104.39
- P/E Ratio
- NEGG N/A
- NSPR N/A
- Revenue Growth
- NEGG N/A
- NSPR 14.04
- 52 Week Low
- NEGG $3.32
- NSPR $1.99
- 52 Week High
- NEGG $137.84
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- NEGG 64.60
- NSPR 30.59
- Support Level
- NEGG $43.00
- NSPR $2.10
- Resistance Level
- NEGG $87.20
- NSPR $2.41
- Average True Range (ATR)
- NEGG 8.96
- NSPR 0.11
- MACD
- NEGG 3.31
- NSPR -0.01
- Stochastic Oscillator
- NEGG 78.66
- NSPR 20.27
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.